Bicycle Therapeutics: Funding, Investors & Team (Oct 2026)
Bicycle Therapeutics is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops which stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical need. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC.
Bicycle Therapeutics has raised $730M across 2 funding rounds on record, the most recent an undisclosed round of $555M announced in May 2024.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Bicycle Therapeutics Company Profile and Key Stats
Latest funding round on record: May 2024.
Bicycle Therapeutics Funding Rounds
Bicycle Therapeutics raised $175M in a Post-IPO Equity announced in Oct 2021.
2.6 years later, an undisclosed round of $555M was announced in May 2024.
Bicycle Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Bicycle Therapeutics Funding Compared to Other Biotechnology Startups
Bicycle Therapeutics' latest round of $555M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Bicycle Therapeutics in Biotechnology and Cambridge
Companies Similar to Bicycle Therapeutics
Microbiotica develops treatments involving live bacteria found in the human microbiome, aiming to identify…
OMass Technologies is a drug discovery company exploiting novel mass spectrometry platforms to develop…
HydRegen, based in Oxford, UK, is a biotech firm that offers eco-friendly alternatives for the production of…
R1 Therapeutics is a clinical‑stage biopharmaceutical company focused on discovering and developing new drug…
The perfect package for any general surgical trainee or resident. Progress from beginner to advanced surgical…
Argonaute RNA company research projects build on existing intellectual property.
An innovative C elegans company that serves the biotech, nutrition, and other industries and fields of study…
ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
Bicycle Therapeutics Funding FAQs
What does Bicycle Therapeutics do?
Bicycle Therapeutics is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops which stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical need. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC.
How much funding has Bicycle Therapeutics raised?
Bicycle Therapeutics has raised $730M across 2 rounds on record. The most recent is an undisclosed round of $555M announced in May 2024.
When did Bicycle Therapeutics last raise funding?
Bicycle Therapeutics' most recent funding round on record is an undisclosed round of $555M, announced in May 2024.
Who founded Bicycle Therapeutics?
FundedIQ lists Christian Heinis (Founder) at Bicycle Therapeutics.
Who is the CEO of Bicycle Therapeutics?
Kevin Lee is listed as CEO at Bicycle Therapeutics.
Where is Bicycle Therapeutics headquartered?
Bicycle Therapeutics is based in Cambridge, Cambridgeshire, United Kingdom.
How many employees does Bicycle Therapeutics have?
Bicycle Therapeutics is in the 101-250 employee band.
How does Bicycle Therapeutics' funding compare to other Biotechnology startups?
Bicycle Therapeutics' latest round of $555M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Bicycle Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Bicycle Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.